Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis – A novel approach-Reference-Cited by-同舟云学术

Combining secukinumab and fingolimod to successfully treat ankylosing spondylitis and multiple sclerosis – A novel approach

Published:2019-07 Issue: Volume:60 Page:93-94
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Nisar Muhammad K.

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference5 articles.

1. Combination therapy with biologic agents in rheumatic diseases: current and future prospects;Inui;Ther. Adv. Musculoskelet. Dis.,2016

2. Interferon beta in multiple sclerosis: experience in a British specialist multiple sclerosis centre;Dubois;J Neurol Neurosurg Psychiatry,2003

3. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis;Kappos;N Engl J Med,2010

4. Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study;Havrdova;J Neurol,2016

5. Treatment of psoriasis and psoriatic arthritis with secukinumab after unsatisfactory response to ustekinumab in multiple sclerosis patient;Assefa;J Dermatol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study;Rheumatology;2023-10-04

2. Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis;Rheumatology;2022-11-28

3. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review;Immunotherapy;2022-04

4. Successful treatment of highly active multiple sclerosis and psoriasis exacerbation with natalizumab and secukinumab combination. A case report and literature review;Neuroimmunology Reports;2022

5. Combination treatment with secukinumab and dimethyl fumarate in a patient with psoriasis and recent diagnosis of multiple sclerosis;Dermatologic Therapy;2020-07-14